Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
36.39MXN
4.78 BMXN
14.08 BMXN
125.65 M
About Halozyme Therapeutics, Inc.
Sector
Industry
CEO
Helen I. Torley
Website
Headquarters
San Diego
Employees (FY)
373
Founded
1998
FIGI
BBG0125C3CZ4
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where HALO is featured.
Frequently Asked Questions
The current price of HALO is 680.00 MXN — it hasn't changed in the past 24 hours. Watch HALOZYME THERAPEUTICS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange HALOZYME THERAPEUTICS INC stocks are traded under the ticker HALO.
HALOZYME THERAPEUTICS INC is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
HALO stock is 0% volatile and has beta coefficient of 1.10. Track HALOZYME THERAPEUTICS INC stock price on the chart and check out the list of the most volatile stocks — is HALOZYME THERAPEUTICS INC there?
HALO earnings for the last quarter are 13.93 MXN per share, whereas the estimation was 13.56 MXN resulting in a 2.68% surprise. The estimated earnings for the next quarter are 11.43 MXN per share. See more details about HALOZYME THERAPEUTICS INC earnings.
HALOZYME THERAPEUTICS INC revenue for the last quarter amounts to 3.91 B MXN despite the estimated figure of 3.92 B MXN. In the next quarter revenue is expected to reach 3.31 B MXN.
Yes, you can track HALOZYME THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
HALO net income for the last quarter is 1.45 B MXN, while the quarter before that showed 1.43 B MXN of net income which accounts for 1.67% change. Track more HALOZYME THERAPEUTICS INC financial stats to get the full picture.
Today HALOZYME THERAPEUTICS INC has the market capitalization of 87.79 B, it has increased by 3.97% over the last week.
No, HALO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HALO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HALOZYME THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
HALO reached its all-time high on Sep 23, 2021 with the price of 841.92 MXN, and its all-time low was 679.74 MXN and was reached on Jan 26, 2022. View more price dynamics on HALO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 7, 2024, the company has 373.00 employees. See our rating of the largest employees — is HALOZYME THERAPEUTICS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HALOZYME THERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HALOZYME THERAPEUTICS INC stock shows the sell signal. See more of HALOZYME THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on HALOZYME THERAPEUTICS INC future price: according to them, HALO price has a max estimate of 1217.59 MXN and a min estimate of 659.53 MXN. Watch HALO chart and read a more detailed HALOZYME THERAPEUTICS INC stock forecast: see what analysts think of HALOZYME THERAPEUTICS INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HALOZYME THERAPEUTICS INC EBITDA is 7.17 B MXN, and current EBITDA margin is 50.94%. See more stats in HALOZYME THERAPEUTICS INC financial statements.